The 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for SLE stipulated the need for a positive anti-nuclear antibody (ANA) test with a titer equal to or exceeding 1:80 [2]. This evidence concerns the gene BTG3 and systemic lupus erythematosus.